| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alport Syndrome Therapeutics: Ready for Prime-Time Players
|
Omachi, Kohei
|
|
2019
|
40 |
11 |
p. 803-806
|
artikel
|
| 2 |
Combating Human Pathogens and Cancer by Targeting Phosphoinositides and Their Metabolism
|
Phan, Thanh Kha
|
|
2019
|
40 |
11 |
p. 866-882
|
artikel
|
| 3 |
Comprehensive Analysis of ERK1/2 Substrates for Potential Combination Immunotherapies
|
Yang, Lei
|
|
2019
|
40 |
11 |
p. 897-910
|
artikel
|
| 4 |
Computational Approaches to Anesthetic Drug Discovery
|
McGrath, Megan
|
|
2019
|
40 |
11 |
p. 809-811
|
artikel
|
| 5 |
Editorial Board and Contents
|
|
|
2019
|
40 |
11 |
p. i-ii
|
artikel
|
| 6 |
Has Drug Design Augmented by Artificial Intelligence Become a Reality?
|
Chen, Hongming
|
|
2019
|
40 |
11 |
p. 806-809
|
artikel
|
| 7 |
miRNAs as Therapeutic Targets in Inflammatory Disease
|
Lu, Qianjin
|
|
2019
|
40 |
11 |
p. 853-865
|
artikel
|
| 8 |
Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way
|
Tkatchenko, Tatiana V.
|
|
2019
|
40 |
11 |
p. 833-852
|
artikel
|
| 9 |
Subscription and Copyright Information
|
|
|
2019
|
40 |
11 |
p. e1
|
artikel
|
| 10 |
The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial
|
John, Peter
|
|
2019
|
40 |
11 |
p. 883-896
|
artikel
|
| 11 |
The Landscape of Atypical and Eukaryotic Protein Kinases
|
Kanev, Georgi K.
|
|
2019
|
40 |
11 |
p. 818-832
|
artikel
|
| 12 |
You Cannot Have Your Synergy and Efficacy Too
|
Sen, Pramita
|
|
2019
|
40 |
11 |
p. 811-817
|
artikel
|
Tijdschrift beschrijving